DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Endroit courant :
> This Story

Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment



Business Affairs Homepage

Varian acquires Noona Healthcare Gains mobile service app that captures PROs

Philly leads US cities in need of radiologists Shortages continue to leave radiologists in high demand

Siemens Healthineers holds grand opening of new Erlangen HQ Continuing its 140 year presence in the city

Does GE CEO move cast doubt on healthcare spinoff? Industry analysts weigh in on how this could change the game plan

Healthcare has a serious problem with wasted spending How supply chain can hold the key to more efficient hospital finances

Mass imaging exam cancellations by VA puts veterans lives at risk Medically needed scans reportedly removed from schedule to reduce backlog

Hologic to acquire Focal Therapeutics for $125 million Furthering its expansion into the breast conservation surgery market

GE CEO Flannery is out as Culp Jr. named chairman and CEO The latest shake-up in a year full of transitions

China tariffs now hit $4.7 billion worth of U.S. medical devices AdvaMed warns that things could get worse before they get better

Philips inks 15-year $75 million MES deal with Children’s Health in Texas Are these contracts the future of value-based care?

Veritas-backed Verscend closes $4.9 billion deal for Cotiviti

par Thomas Dworetzky , Contributing Reporter
Verscend, a data-driven healthcare solutions provider and portfolio company of Veritas Capital, has closed its $4.9 billion cash deal for healthcare industry payment accuracy and analytics provider, Cotiviti.

“We believe Cotiviti is a perfect fit with both our investment strategy and with Verscend, and we look forward to taking the platform to the next level through this exciting combination,” said Ramzi Musallam, CEO and Managing Partner of Veritas Capital, in a statement when the deal was announced.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

Veritas aims to invest in such “transformational impact,” noted Musallam on the closing of the deal. “We see the combination of Cotiviti and Verscend as bringing much needed precision and insight to the healthcare system,” he stated. “We expect that the two companies’ complementary data sets, analytical capabilities, and industry expertise will accelerate forward momentum for the new Cotiviti through smarter, faster solutions that address rising costs, eliminate waste, and speed quality improvement for the healthcare industry overall.”

The deal delivered $44.75 in cash for each Cotiviti common stock, plus the assumption of all outstanding debt by Verscend.

The two will run as a combined private company under the name of Cotiviti and Dr. Emad Rizk, Verscend president and CEO, will retain his titles in the new firm.

“We are thrilled to partner with Cotiviti, which has become an important player in the growing and increasingly important and complex healthcare payment accuracy space,” said Rizk when the deal was announced in June.

The combined company is aiming at one of the greatest challenges in healthcare financial performance – getting the payments right and catching fraud, waste and abuse. Having both financial and clinical data with which to work, Cotiviti “will have unique insight” into healthcare finances in a rapidly changing landscape.

“Both companies are customer-driven innovators that share a similar mission: to help our clients improve healthcare affordability, reduce waste, and identify the best path to better outcomes,” said Rizk. “With our new capabilities across payment, quality, risk, and the combination of clinical and financial data, Cotitivi will be unmatched in its ability to create differentiated value for its clients.”

Veritas Capital was in the news lately with its GE Healthcare’s Value-Based Care Division acquisition, which closed in July.

When it closed the billion-dollar deal, Musallam called it “an exciting chapter.”

The deal followed the “corporate carve-out” pattern of prior Veritas investments in healthcare tech – including those in Truven Health Analytics and Verscend.

IBM acquired Truven Health Analytics, a provider of cloud-based health care data, analytics and insights, for $2.6 billion in 2016 from Veritas.

The Truven purchase showed “we’re serious, and spending serious money to move fast in a whole new industry for IBM,” John E. Kelly, IBM senior vice president, said at the time.

Veritas Capital had bought Truven from Thomson Reuters for $1.25 billion in 2012, according to Reuters.

Business Affairs Homepage

You Must Be Logged In To Post A Comment

Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2018, Inc.